DU145細胞

DU145(DU-145)是人類前列腺癌細胞系。DU145、PC3和LNCaP被認為是用於治療研究的標準前列腺癌細胞系[1]。DU145細胞系源自原發性前列腺腺癌的中樞神經系統遠端轉移,在頂枕開顱手術 (parietooccipital craniotomy) 中被切除[2]雄激素受體陽性的DU145對激素不敏感,並且不表達前列腺特異抗原。 DU145細胞與具有高轉移潛力的PC3細胞相比,具有中等的轉移潛力[3]

依託泊苷誘導的DU145細胞凋亡。

參考資料

  1. ^ Alimirah, F; Chen, J; Basrawala, Z; Xin, H; Choubey, D. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation.. FEBS letters. 2006-04-17, 580 (9): 2294–300 [2019-11-25]. PMID 16580667. doi:10.1016/j.febslet.2006.03.041. 
  2. ^ Stone, KR; Mickey, DD; Wunderli, H; Mickey, GH; Paulson, DF. Isolation of a human prostate carcinoma cell line (DU 145).. International journal of cancer. 1978-03-15, 21 (3): 274–81 [2019-11-25]. PMID 631930. doi:10.1002/ijc.2910210305. 
  3. ^ Pulukuri, SM; Gondi, CS; Lakka, SS; Jutla, A; Estes, N; Gujrati, M; Rao, JS. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.. The Journal of biological chemistry. 2005-10-28, 280 (43): 36529–40 [2019-11-25]. PMID 16127174. doi:10.1074/jbc.M503111200. 

外部連結